Gearhart M O, Sorg T B
Department of Pharmacy, Good Samaritan Hospital and Health Center, Dayton, OH 45406.
Ann Pharmacother. 1993 Mar;27(3):285-9. doi: 10.1177/106002809302700304.
To report a case of possible foscarnet-induced severe hypomagnesemia and other electrolyte disorders.
An AIDS patient experienced an exacerbation of cytomegalovirus retinitis and was treated with foscarnet. The patient experienced muscle twitches, tremulousness, and anxiety on day 17 of foscarnet therapy. Laboratory results indicated hypomagnesemia, hypocalcemia, hypokalemia, and hypophosphatemia. After electrolyte supplementation and discontinuation of foscarnet, the symptoms resolved and laboratory indices returned to normal.
Electrolyte disorders associated with foscarnet are reviewed. Severe hypomagnesemia occurred in this patient and published literature is highlighted. In addition, known and/or possible mechanisms of the disorders are discussed.
It is probable that foscarnet contributed to the electrolyte disorders and symptomatology in this patient. Electrolytes must be monitored frequently during foscarnet therapy. Also, concomitant therapy with antianxiety medications that may mask the symptoms of electrolyte disorders should be undertaken with caution.
报告一例可能由膦甲酸钠引起的严重低镁血症及其他电解质紊乱病例。
一名艾滋病患者巨细胞病毒性视网膜炎病情加重,接受了膦甲酸钠治疗。在膦甲酸钠治疗的第17天,患者出现肌肉抽搐、震颤和焦虑。实验室检查结果显示低镁血症、低钙血症、低钾血症和低磷血症。补充电解质并停用膦甲酸钠后,症状缓解,实验室指标恢复正常。
对与膦甲酸钠相关的电解质紊乱进行了综述。该患者出现了严重低镁血症,并突出了已发表的文献。此外,还讨论了这些紊乱已知和/或可能的机制。
膦甲酸钠很可能导致了该患者的电解质紊乱和症状。在膦甲酸钠治疗期间必须频繁监测电解质。此外,应谨慎使用可能掩盖电解质紊乱症状的抗焦虑药物进行联合治疗。